Eragen Biosciences

Molecular Reagent Products and molecular diagnostic products for early detection and monitoring of cancer, genetic and infectious diseases.

placeMadison, Wisconsin, United States calendar_todayFounded 1994 groups50 employees language eragen.com

Innovation

15 patent families (8 granted) — focus: Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 1,193 times.

YearFilings
20123
20132
20141
20171
20231

Investor mix

7 investors on record; lead investors include First Analysis, Prolog Ventures; 1 has since exited.

Investor typeCountShare
Venture capital229%
Private equity114%
Angel & family office114%
Bank & private debt114%
Other / undisclosed229%
Coming soon